Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $15.13, but opened at $14.35. Fresenius SE & Co. shares last traded at $14.35, with a volume of 3,698 shares trading hands.
Analysts Set New Price Targets
A number of analysts have weighed in on FSNUY shares. Morgan Stanley restated an “overweight” rating on shares of Fresenius SE & Co. in a report on Monday, December 15th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Fresenius SE & Co. in a research note on Monday, October 27th. Two research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy”.
Read Our Latest Research Report on FSNUY
Fresenius SE & Co. Stock Up 0.5%
Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its earnings results on Wednesday, November 5th. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.21 by $0.02. Fresenius SE & Co. had a return on equity of 9.72% and a net margin of 5.26%.The company had revenue of $6.29 billion for the quarter, compared to analyst estimates of $6.38 billion. Analysts forecast that Fresenius SE & Co. will post 0.79 earnings per share for the current year.
About Fresenius SE & Co.
Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.
The company operates through four main business segments.
Featured Stories
- Five stocks we like better than Fresenius SE & Co.
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Fresenius SE & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. and related companies with MarketBeat.com's FREE daily email newsletter.
